CD4 and myeloid sarcoma: As previously reported [47], HAM/TSP patients showed decreased expressions of FoxP3 and CTLA-4 in CD4+CD25+ T cells of the peripheral blood compared to NDs and subjects with MS and PML (Fig 4C and 4D, respectively).